Bioengineering solutions for neural repair and recovery in stroke

Current Opinion in Neurology

Volumn 26, Issue 6, 2013, Pages 626-631

  Modo, Michel ^a,b   Ambrosio, Fabrisia ^a,b   Friedlander, Robert M ^b   Badylak, Stephen F ^a,b   Wechsler, Lawrence R ^a,c  

^a MCGOWAN INSTITUTE FOR REGENERATIVE MEDICINE   (United States)

^b Department of Radiology ^*  (United States)

^c UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

Author keywords

Biomaterial; Brain computer interface; Physical therapy; Rehabilitation; Robot assisted; Stroke; Tissue engineering

Indexed keywords

ALGINIC ACID; AMPHETAMINE; BIOMATERIAL; DIZOCILPINE; EPIDERMAL GROWTH FACTOR; ERYTHROPOIETIN; HYALURONIC ACID; METHYLCELLULOSE;

BIOENGINEERING; BRAIN COMPUTER INTERFACE; CELL ENCAPSULATION; CEREBROVASCULAR ACCIDENT; DISABILITY; DRUG DELIVERY SYSTEM; ELECTROSTIMULATION; EXTRACELLULAR FLUID; EXTRACELLULAR MATRIX; HUMAN; HYDROGEL; NERVE CELL PLASTICITY; NERVOUS SYSTEM DEVELOPMENT; NEURAL STEM CELL TRANSPLANTATION; NEUROBIOLOGY; NEUROPROTECTION; NONHUMAN; PARALYSIS; PHYSIOTHERAPY; REGENERATIVE MEDICINE; REHABILITATION; REVIEW; ROBOTIC EXOSKELETON; STEREOTAXIC SURGERY; SUSTAINED DRUG RELEASE; TISSUE ENGINEERING; TRAINING; ANIMAL; CONVALESCENCE; NERVE CELL; PHYSIOLOGY; PROCEDURES; REGENERATION; STROKE;

ANIMALS; BIOENGINEERING; HUMANS; NEURONS; RECOVERY OF FUNCTION; REGENERATION; STROKE;

EID: 84892364063     PISSN: 13507540     EISSN: 14736551     Source Type: Journal    
DOI: 10.1097/WCO.0000000000000031     Document Type: Review

References (65)

1. Carmichael ST. Plasticity of cortical projections after stroke. Neuroscientist 2003;9:64-75.
2. WHO. Neurological disorder: public health challenges. Geneva, Switzerland: World Health Organization;2006.
3. Cumberland Consensus Working Group. Cheeran B, Cohen L, Ford G, et al. The future of restorative neurosciences in stroke: driving the translational research pipeline from basic science to rehabilitation of people after stroke. Neurorehabil Neural Repair 2009;23:97-107.
4. Reza Noorian A, Nogueira R, Gupta R. Neuroprotection in acute ischemic stroke. J Neurosurg Sci 2011;55:127-138.
5. Hachinski V, Donnan GA, Gorelick PB, et al. Stroke: working toward a prioritized world agenda. Stroke 2010;41:1084-1099.
6. Harbeck-Seu A, Brunk I, Platz T, et al. A speedy recovery: Amphetamines and other therapeutics that might impact the recovery from brain injury. Curr Opin Anaesthesiol 2011; 24:144-153.
7. Schurr A. Neuroprotection against ischemic/hypoxic brain damage: blockers of ionotropic glutamate receptor and voltage sensitive calcium channels. Curr Drug Targets 2004; 5:603-618.
8. Olney JW, Labruyere J, Wang G, et al. NMDA antagonist neurotoxicity: mechanism and prevention. Science 1991; 254:1515-1518.
9. Kim ID, Lim CM, Kim JB, et al. Neuroprotection by biodegradable PAMAM ester (e-PAM-R)-mediated HMGB1 siRNA delivery in primary cortical cultures and in the postischemic brain. J Control Release 2010; 142:422-430.
10. Jin YC, Kim SW, Cheng F, et al. The effect of biodegradable gelatin microspheres on the neuroprotective effects of high mobility group box 1 A box in the postischemic brain. Biomaterials 2011; 32:899-908.
11. Bible E, Chau DY, Alexander MR, et al. Attachment of stem cells to scaffold particles for intra-cerebral transplantation. Nat Protoc 2009; 4:1440-1453.
12. Bertram JP, Rauch MF, Chang K, Lavik EB. Using polymer chemistry to modulate the delivery of neurotrophic factors from degradable microspheres: delivery of BDNF. Pharm Res 2010; 27:82-91.
13. Bjugstad KB, Lampe K, Kern DS, Mahoney M. Biocompatibility of poly(ethylene glycol)-based hydrogels in the brain: An analysis of the glial response across space and time. J Biomed Mater Res A 2010; 95:79-91.
14. Lampe KJ, Bjugstad KB, Mahoney MJ. Impact of degradable macromer content in a poly(ethylene glycol) hydrogel on neural cell metabolic activity, redox state, proliferation, and differentiation. Tissue Eng Part A 2010; 16:1857-1866.
15. Bjugstad KB, Redmond DE Jr, Lampe KJ, et al. Biocompatibility of PEGbased hydrogels in primate brain. Cell Transplant 2008; 17:409-415.
16. Cooke MJ, Wang Y, Morshead CM, Shoichet MS. Controlled epi-cortical delivery of epidermal growth factor for the stimulation of endogenous neural stem cell proliferation in stroke-injured brain. Biomaterials 2011; 32:5688- 5697.
17. Wang Y, Cooke MJ, Morshead CM, Shoichet MS. Hydrogel delivery of erythropoietin to the brain for endogenous stem cell stimulation after stroke injury. Biomaterials 2012; 33:2681-2692.
18. Lampe KJ, Kern DS, Mahoney MJ, Bjugstad KB. The administration of BDNF and GDNF to the brain via PLGA microparticles patterned within a degradable PEG-based hydrogel: protein distribution and the glial response. J Biomed Mater Res A 2011; 63:595-607.
19. Bible E, Qutachi O, Chau DY, et al. Neo-vascularization of the stroke cavity by implantation of human neural stem cells on VEGF-releasing PLGA microparticles. Biomaterials 2012; 33:7435-7446.
20. Chu H, Gao J, Chen CW, et al. Injectable fibroblast growth factor-2 coacervate for persistent angiogenesis. Proc Natl Acad Sci U S A 2011; 108:13444-13449.
21. Candelario-Jalil E. Injury and repair mechanisms in ischemic stroke: Considerations for the development of novel neurotherapeutics. Curr Opin Investig Drugs 2009; 10:644-654.
22. Qutachi O, Shakesheff KM, Buttery LD. Delivery of definable number of drug or growth factor loaded poly(dl-lactic acid-co-glycolic acid) microparticles within human embryonic stem cell derived aggregates. J Control Release 2013; 168:18-27.
23. Bible E, Chau DY, Alexander MR, et al. The support of neural stem cells transplanted into stroke-induced brain cavities by PLGA particles. Biomaterials 2009; 30:2985-2994.
24. Orive G, Anitua E, Pedraz JL, Emerich DF. Biomaterials for promoting brain protection, repair and regeneration. Nat Rev Neurosci 2009; 10:682- 692.
25. Emerich DF, OriveG, Borlongan C. Tales of biomaterials, molecules, and cells for repairing and treating brain dysfunction. Curr Stem Cell Res Ther 2011; 6:171-189.
26. Smith EJ, Stroemer RP, Gorenkova N, et al. Implantation site and lesion topology determine efficacy of a human neural stem cell line in a rat model of chronic stroke. Stem Cells 2012; 30:785-796.
27. Aebischer P, Buchser E, Joseph JM, et al. Transplantation in humans of encapsulated xenogeneic cells without immunosuppression. A preliminary report. Transplantation 1994; 58:1275-1277.
28. Bachoud-Levi AC, Deglon N, Nguyen JP, et al. Neuroprotective gene therapy for Huntington's disease using a polymer encapsulated BHK cell line engineered to secrete human CNTF. Hum Gene Ther 2000; 11:1723-1729.
29. Aebischer P, Tresco PA, Winn SR, et al. Long-term cross-species brain transplantation of a polymer-encapsulated dopamine-secreting cell line. Exp Neurol 1991; 111:269-275.
30. Bloch J, Bachoud-Levi AC, Deglon N, et al. Neuroprotective gene therapy for Huntington's disease, using polymer-encapsulated cells engineered to secrete human ciliary neurotrophic factor: Results of a phase I study. Hum Gene Ther 2004; 15:968-975.
31. Aebischer P, Schluep M, Deglon N, et al. Intrathecal delivery of CNTF using encapsulated genetically modified xenogeneic cells in amyotrophic lateral sclerosis patients. Nat Med 1996; 2:696-699.
32. Santos E, Pedraz JL, Hernandez RM, Orive G. Therapeutic cell encapsulation: Ten steps towards clinical translation. J Control Release 2013; 170:1-14.
33. Jin K, Mao X, Xie L, et al. Transplantation of human neural precursor cells in Matrigel scaffolding improves outcome from focal cerebral ischemia after delayed postischemic treatment in rats. J Cereb Blood Flow Metab 2010; 30:534-544.
34. .Kim H, Cooke MJ, Shoichet MS. Creating permissive microenvironments for stem cell transplantation into the central nervous system. Trends Biotechnol 2012; 30:55-63.
35. Yu H, Cao B, Feng M, et al. Combinated transplantation of neural stem cells and collagen type I promote functional recovery after cerebral ischemia in rats. Anat Rec 2010; 293:911-917.
36. Park KI, Teng YD, Snyder EY. The injured brain interacts reciprocally with neural stem cells supported by scaffolds to reconstitute lost tissue. Nat Biotechnol 2002; 20:1111-1117.
37. Novosel EC, Kleinhans C, Kluger PJ. Vascularization is the key challenge in tissue engineering. Adv Drug Deliv Rev 2011; 63:300-311.
38. Franco CL, Price J, West JL. Development and optimization of a dualphotoinitiator, emulsion-based technique for rapid generation of cell-laden hydrogel microspheres. Acta Biomater 2011; 7:3267-3276.
39. Pakulska MM, Ballios BG, Shoichet MS. Injectable hydrogels for central nervous system therapy. Biomed Mater 2012; 7:024101.
40. Moshayedi P, Carmichael ST. Hyaluronan, neural stem cells and tissue reconstruction after acute ischemic stroke. Biomatter 2013; 3:3267-3276.
41. Medberry CJ, Crapo PM, Siu BF, et al. Hydrogels derived from central nervous system extracellular matrix. Biomaterials 2013; 34:1033-1040.
42. Bible E, Dell'Acqua F, Solanky B, et al. Noninvasive imaging of transplanted human neural stem cells and ECM scaffold remodeling in the stroke-damaged rat brain by (19)F- And diffusion-MRI. Biomaterials 2012; 33:2858-2871.
43. El-Akabawy G, Medina LM, Jeffries A, et al. Purmorphamine increases DARPP-32 differentiation in human striatal neural stem cells through the Hedgehog pathway. Stem Cells Dev 2011; 20:1873-1887.
44. Caicco MJ, Cooke MJ, Wang Y, et al. A hydrogel composite system for sustained epi-cortical delivery of cyclosporin A to the brain for treatment of stroke. J Control Release 2013; 166:197-202.
45. Dobrossy M, Busse M, Piroth T, et al. Neurorehabilitation with neural transplantation. Neurorehabil Neural Repair 2010; 24:692-701.
46. Jones TA, Allred RP, Adkins DL, et al. Remodeling the brain with behavioral experience after stroke. Stroke 2009; 40 (3 Suppl):S136-S138.
47. Cicerone KD. Facts, theories, values: shaping the course of neurorehabilitation. The 60th John Stanley Coulter memorial lecture. Arch Phys Med Rehabil 2012; 93:188-191.
48. Stinear C, Ackerley S, Byblow W. Rehabilitation is initiated early after stroke, but most motor rehabilitation trials are not: A systematic review. Stroke 2013; 44:2039-2045.
49. Sullivan JE, Crowner BE, Kluding PM, et al. Outcome measures for individuals with stroke: Recommendations from the American Physical Therapy Association Neurology Section Task Force. Phys Ther 2013; 93:1383-1396.
50. Zhang M, Lange B, Chang CY, et al. Beyond the standard clinical rating scales: fine-grained assessment of poststroke motor functionality using wearable inertial sensors. Conf Proc IEEE Eng Med Biol Soc 2012; 2012:6111-6115.
51. Tretriluxana J, Runnarong N, Tretriluxana S, et al. Feasibility investigation of the Accelerated Skill Acquisition Program (ASAP): Insights into reach-to-grasp coordination of individuals with postacute stroke. Top Stroke Rehabil 2013; 20:151-160.
52. Dobkin BH. Neurobiology of rehabilitation. Ann N Y Acad Sci 2004; 1038:148-170.
53. Whishaw IQ, Alaverdashvili M, Kolb B. The problem of relating plasticity and skilled reaching after motor cortex stroke in the rat. Behav Brain Res 2008; 192:124-136.
54. Krakauer JW, Carmichael ST, Corbett D, Wittenberg GF. Getting neurorehabilitation right: what can be learned from animal models? Neurorehabil Neural Repair 2012; 26:923-931.
55. Lo AC. Clinical designs of recent robot rehabilitation trials. Am J Phys Med Rehabil 2012; 91 (11 Suppl 3):S204-S216.
56. Krebs HI. Rehabilitation robotics: An academic engineer perspective. Conf Proc IEEE Eng Med Biol Soc 2011; 2011:6709-6712.
57. Loureiro RC, Harwin WS, Nagai K, Johnson M. Advances in upper limb stroke rehabilitation: A technology push. Med Biol Eng Comput 2011; 49:1103- 1118.
58. Frisoli A, Procopio C, Chisari C, et al. Positive effects of robotic exoskeleton training of upper limb reaching movements after stroke. J Neuroeng Rehabil 2012; 9:36.
59. Ren Y, Kang SH, Park HS, et al. Developing a multijoint upper limb exoskeleton robot for diagnosis, therapy, and outcome evaluation in neurorehabilitation. IEEE Trans Neural Syst Rehabil Eng 2013; 21:490-499.
60. Scott SH, Dukelow SP. Potential of robots as next-generation technology for clinical assessment of neurological disorders and upper-limb therapy. J Rehabil Res Dev 2011; 48:335-353.
61. Macintosh BJ, Graham SJ. Magnetic resonance imaging to visualize stroke and characterize stroke recovery: A review. Front Neurol 2013; 4:60.
62. Crum WR, Giampietro VP, Smith EJ, et al. A comparison of automated anatomical-behavioural mapping methods in a rodent model of stroke. J Neurosci Methods 2013; 218:170-183.
63. Granziera C, Daducci A, Meskaldji DE, et al. A new early and automated MRIbased predictor of motor improvement after stroke. Neurology 2012; 79:39- 46.
64. Collinger JL, Wodlinger B, Downey JE, et al. High-performance neuroprosthetic control by an individual with tetraplegia. Lancet 2013; 381:557- 564.
65. Carrera I, Moreno HA, Saltaren R, et al. ROAD: domestic assistant and rehabilitation robot. Med Biol Eng Comput 2011; 49:1201-1211.